Shows & Events 2010
| Event or Convention | Location | Exhibit Dates | Exhibit No. |
|---|---|---|---|
| Texas Medical Center | Houston, TX | Feb 25 | n/a |
| American Association For Cancer Research (AACR) | Washington, DC | April 17-21 | 1602 |
| Experimental Biology (EB) | Anaheim, CA | April 24-28 | 242 |
| American Association of Immunologists (AAI) | Baltimore, MD | May 7-11 | 913 |
| NIH Research Festival | Bethesda, MD | May 12-13 | 414 |
| Canadian Neuroscience | Ottawa, ON | May 15-18 | 5 |
| The Endocrine Society | San Diego, CA | June 19-22 | 828 |
| The Federation of European Neuroscience (FENS) | Amsterdam | July 3-7 | 505 |
| Harvard Medical School | Boston, MA | July 29 | n/a |
| Biogen / Novartis / MIT | Cambridge, MA | July 30 | n/a |
| American Association of Laboratory Animal Science (AALAS) | Atlanta, GA | Oct 10-14 | 1631 |
| Society for Neuroscience (SFN) | San Diego, CA | Nov 13-17 | 2313 |
Researchers are saying...
“Nonspecific toxicity is a common problem associated with in vivo application of antisense oligonucleotides.However, by employing certain strategies including the use of partial rather than complete phosphorothioate modification, reducing the length of the oligonucleotide, and using a steady continuous infusion rather than bolus injections, we were able to minimize such toxicity (Van Kampen & Stoessl, 2000a).” (p. 309) Van Kampen et al., Neuroscience 2003;116:307-314.
